A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
2003 • 7,470 citations
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
2004 • 4,872 citations
CD4+CD25+ suppressor T cells: more questions than answers
2002 • 2,202 citations
Regulatory T cells in transplantation tolerance
2003 • 1,323 citations
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
2006 • 1,180 citations
Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood
2001 • 1,168 citations
Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse
2006 • 1,118 citations
Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function
2001 • 1,008 citations
Prevalence of FOXP3+ Regulatory T Cells Increases During the Progression of Pancreatic Ductal Adenocarcinoma and Its Premalignant Lesions
2006 • 746 citations
Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.
1982 • 640 citations
Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells
2001 • 615 citations
Regulatory T cells under scrutiny
2003 • 427 citations
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
2008 • 395 citations
Antigen-induced regulatory T cells in autoimmunity
2003 • 317 citations
Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells
2008 • 294 citations
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 • 201 citations
Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target
2008 • 132 citations
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer
2006 • 122 citations
Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer
2007 • 121 citations
Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis.
2007 • 119 citations
Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)
2007 • 100 citations
Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer
2008 • 94 citations
Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma
2007 • 89 citations
The impact of regulatory T cells on carcinogen-induced sarcogenesis
2007 • 68 citations
Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases
2007 • 59 citations
Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity
1990 • 59 citations
Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
1997 • 49 citations
Cited By (0)
No citing papers found in database